High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin

Cancer Investigation

Volumn 28, Issue 4, 2010, Pages 340-349

  Sharma, Ashok ^a   Ray, Ruma ^a   Rajeswari, Moganty R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Cisplatin; HMGA1 protein; Necrosis; Skin; Squamous cell carcinoma

Indexed keywords

CISPLATIN; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A1B PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HMGA1A PROTEIN; HMGA1B PROTEIN; MICE; SKIN NEOPLASMS;

EID: 77950577780     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903286933     Document Type: Article

References (44)

1. Bustin, M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001, 26, 152-153.
2. Bustin, M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility group chromosomal proteins. Mol Cell Biol 1999, 19, 5237-5246.
3. Rajeswari, M.R.; Jain, A. High-mobility group chromosomal proteins, HMGA1 as potential tumor markers. Current Sci 2002, 82, 838-844.
4. Johnson, K.R.; Lehn, D.A.; Reeves, R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol 1989, 9, 2114-2123.
5. Cattaruzzi, G.; Altamura, S.; Tessari, M.A.; Rustighi, A.; Giancotti, V.; Pucillo, C.; Manfioletti, G. The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and function. Nucleic Acids Res 2007, 35, 1751-1760.
6. Disney, J.E.; Johnson, K.R.; Magnuson, N.S.; Sylvester, S.R.; Reeves, R. High-mobility group protein HMG-I localizes to G/Qand C-bands of human and mouse chromosomes. J Cell Biol 1989, 109, 1975-1982.
7. Reeves, R.; Beckerbauer, L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 2001, 1519, 13-29.
8. Harer, M.; Luhrs, H.; Bustin, M.; Scheer, U.; Hook, R. Dynamic interaction of HMGA1a proteins with chromatin. J Cell Sci 2004, 117, 3459-3471.
9. Reeves, R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001, 277, 63-81.
10. Cleynen, I.; Huysmans, C.; Sasazuki, T.; Shirasawa, S.; Van de Ven, W.; Peeters, K. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression. Cancer Res 2007, 67, 4620-4629.
11. Cleynen, I.; Van de Ven, W.J. The HMGA proteins: a myriad of functions. Int J Onco 2008, 32, 289-305.
12. Wan, W.; Wang, W.; Li, A.D. HMGA1a protein unfolds or refolds synthetic DNA-chromophore hybrid polymers: a chaperone-like behavior. Chembiochem 2008, 9, 304-311.
13. Wisniewski, J.R.; Schwanbeck, R. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation. Int J Mol Med 2000, 6, 409-419.
14. Liau, S.S.; Jazag, A.; Whang, E.E. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma. Cancer Res 2006, 66, 11613-11622.
15. Rajeswari, M.R.; Singh, D.; Jain, A.; Ray, R. Elevated levels of high-mobility group chromosomal proteins, HMGA1, inmurine skin carcinoma. Cancer Lett 2001, 173, 93-99.
16. Chiappetta, G.; Avantaggiato, V.; Visconti, R.; Fedele, M.; Battista, S.; Trapasso, F.; Merciai, B.M.; Fidanza, V.; Giancotti, V.; Santoro, M.; Simeone, A.; Fusco, A. High-level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996, 13, 2439-2446.
17. Singh, D.; Rajeswari, M.R. Enhanced Expression of HMG-Y proteins in proliferating tissues. Ind J Clini Biocem 2001, 16, 72-76.
18. Chu, G. Cellular responses to Cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 1994, 269, 787-790.
19. Chu, G. Cellular response to Cisplatin. J Biol Chem 1994, 269, 787-790.
20. Wang, D.; Lippard, S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discovery 2005, 4, 307-320.
21. Jordan, P.; Carmo-Fonseca, M. Molecular mechanisms involved in Cisplatin cytotoxicity. Cell Mol Life Sci 2000, 57, 1229-1235.
22. Roy, M. The role of base excision repair in Cisplatin-DNA adduct repair and cellular resistance to Cisplatin. Journal@rchive 2000, 3, 63-69.
23. Baldassarre, G.; Belletti, B.; Battista, S.; Nicoloso, M.S.; Pentimalli, F.; Fedele, M.; Croce, C.M.; Fusco, A. HMGA1 protein expression sensitizes cells to Cisplatin-induced cell death. Oncogene 2005, 24, 6809-6819.
24. Adair, J.E.; Kwon, Y.; Dement, G.A.; Smerdon, M.J.; Reeves, R. Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J Biol Chem 2005, 280, 32184-32192.
25. Casanova,M.L.; Blazquez, C.; Martinez-Palacio, J.; Villanueva, C.; Fernandez-Acenero, M.J.; Huffman, J.W.; Jorcano, J.L.; Guzman, M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003, 111, 43-50.
26. Martelli, A.M.; Riccio, M.; Bareggi, R.; Manfioletti, G.; Tabellini, G.; Baldini, G.; Narducci, P.; Giancotti, V. Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study. J Histochem Cytochem 1998, 46, 863-864.
27. Martinez Hoyos, J.; Fedele, M.; Battista, S.; Pentimalli, F.; Kruhoffer, M.; Arra, C.; Orntoft, T.F.; Croce, C.M.; Fusco, A. Identification of the genes up- and down-regulated by the high-mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res 2004, 64, 5728-5735.
28. Giannini, G.; Cerignoli, F.; Mellone, M.; Massimi, I.; Ambrosi, C.; Rinaldi, C.; Dominici, C.; Frati, L.; Screpanti, I.; Gulino, A. High-mobility group A1 is a molecular target for MYCN in human neuroblastoma. Cancer Res 2005, 65, 8308-8316.
29. Pierantoni, G.M.; Fedele, M.; Pentimalli, F.; Benvenuto, G.; Pero, R.; Viglietto, G.; Santoro, M.; Chiariotti, L.; Fusco, A. High-mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 2001, 20, 6132-6141.
30. Liberati, C.; Sgarra, R.; Manfioletti, G.; Mantovani, R. DNA binding of NF-Y: the effect of HMGI proteins depends upon the CCAAT box. FEBS Lett 1998, 433, 174-178.
31. Di Stefano, V.; Rinaldo, C.; Sacchi, A.; Soddu, S.; D'Orazi, G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for Cisplatin-mediated apoptosis. Exp Cell Res 2004, 293, 311-320.
32. Pierantoni, G.M.; Rinaldo, C.; Esposito, F.; Mottolese, M.; Soddu, S.; Fusco, A. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ 2006, 13, 1554-1563.
33. Rinaldo, C.; Prodosmo, A.; Siepi, F.; Soddu, S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem Cell Biol 2007, 85, 411-418.
34. Narita, M.; Narita, M.; Krizhanovsky, V.; Nũnez, S.; Chicas, A.; Hearn, S.A.; Myers, M.P.; Lowe, S.W. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006, 126, 503-514.
35. Gonzalez, V.M.; Fuertes, M.A.; Alonso, C.; Perez, J.M. Is Cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 2001, 59, 657-663.
36. Nicotera, P.; Melino, G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23, 2757-2765.
37. Fedele, M.; Pierantoni, G.M.; Berlingieri, M.T.; Battista, S.; Baldassarre, G.; Munshi, N.; Dentice, M.; Thanos, D.; Santoro, M.; Viglietto, G.; Fusco, A. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res 2001, 61, 4583-4590.
38. Sgarra, R.; Rustighi, A.; Tessari, M.A.; Di Bernardo, J.; Altamura, S.; Fusco, A.; Manfioletti, G.; Giancotti, V. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett 2004, 574, 1-8.
39. Zhang, Q.; Zhang, K.; Zou, Y.; Perna, A.; Wang, Y. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. J Am Soc Mass Spectrum 2007, 18, 1569-1578.
40. Adair, J.E.; Maloney, S.C.; Dement, G.A.;Wertzler, K.J.; Smerdon, M.J.; Reeves, R. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. Cancer Res 2007, 67, 6044-6052.
41. Maloney, S.C.; Adair, J.E.; Smerdon, M.J.; Reeves, R. Genespecific nucleotide excision repair is impaired in human cells expressing elevated levels of high-mobility group A1 nonhistone proteins. DNA Repair 2007, 6, 1371-1379.
42. Diana, F.; Sgarra, R.; Manfioletti, G.; Rustighi, A.; Poletto, D.; Sciortino, M.T.; Mastino, A.; Giancotti, V. A link between apoptosis and degree of phosphorylation of high-mobility group A1a protein in leukemic cells. J Biol Chem 2001, 276, 11354-11361.
43. Andrews, P.A.; Howell, S.B. Cellular pharmacology of Cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990, 2, 35-43.
44. Piekielko, A.; Drung, A.; Rogalla, P.; Schwanbeck, R.; Heyduk, T.; Gerharz, M.; Bullerdiek, J.; Winiewski, J.R. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem 2001, 276, 1984-1992.